Fidelity Investments’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-295,622
| Closed | -$15.6M | – | 5716 |
|
|
2026
Q1 | $15.6M | Sell |
295,622
-731,241
| -71% | -$30M | ﹤0.01% | 1873 |
|
|
2025
Q4 | $41.5M | Buy |
1,026,863
+966,513
| +1,602% | +$22.3M | ﹤0.01% | 1510 |
|
|
2025
Q3 | $453K | Buy |
60,350
+1,401
| +2% | +$8.95K | ﹤0.01% | 3065 |
|
|
2025
Q2 | $220K | Buy |
58,949
+57,587
| +4,228% | +$180K | ﹤0.01% | 3273 |
|
|
2025
Q1 | $3.76K | Sell |
1,362
-112,559
| -99% | -$460K | ﹤0.01% | 4774 |
|
|
2024
Q4 | $631K | Sell |
113,921
-1,058,603
| -90% | -$7.17M | ﹤0.01% | 2833 |
|
|
2024
Q3 | $9.78M | Sell |
1,172,524
-1,594,572
| -58% | -$13.1M | ﹤0.01% | 1929 |
|
|
2024
Q2 | $18.8M | Buy |
2,767,096
+4,970
| +0.2% | +$30.1K | ﹤0.01% | 1676 |
|
|
2024
Q1 | $18.1M | Sell |
2,762,126
-228,276
| -8% | -$1.49M | ﹤0.01% | 1693 |
|
|
2023
Q4 | $19.4M | Sell |
2,990,402
-2,127,648
| -42% | -$11.2M | ﹤0.01% | 1637 |
|
|
2023
Q3 | $25.7M | Sell |
5,118,050
-1,932,296
| -27% | -$12.3M | ﹤0.01% | 1489 |
|
|
2023
Q2 | $61.7M | Sell |
7,050,346
-592,412
| -8% | -$6.9M | 0.01% | 1191 |
|
|
2023
Q1 | $90.5M | Buy |
7,642,758
+264,117
| +4% | +$2.52M | 0.01% | 1021 |
|
|
2022
Q4 | $75.1M | Buy |
7,378,641
+7,277,002
| +7,160% | +$48.4M | 0.01% | 1085 |
|
|
2022
Q3 | $599K | Sell |
101,639
-36
| -0% | -$134 | ﹤0.01% | 2740 |
|
|
2022
Q2 | $252K | Sell |
101,675
-2,219,783
| -96% | -$4.43M | ﹤0.01% | 3069 |
|
|
2022
Q1 | $6.89M | Sell |
2,321,458
-479,527
| -17% | -$2.05M | ﹤0.01% | 2262 |
|
|
2021
Q4 | $19.8M | Sell |
2,800,985
-132,177
| -5% | -$1.1M | ﹤0.01% | 1830 |
|
|
2021
Q3 | $30.6M | Sell |
2,933,162
-89,395
| -3% | -$927K | ﹤0.01% | 1642 |
|
|
2021
Q2 | $37.1M | Buy |
3,022,557
+134,819
| +5% | +$2.3M | ﹤0.01% | 1570 |
|
|
2021
Q1 | $63.5M | Buy |
+2,887,738
| New | +$63.3M | 0.01% | 1284 |
|
Other funds holding TERN
Fidelity Investments's TERN Position: Q2 2026 in Review
Fidelity Investments sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 295,622 shares — an estimated $15.6M sold.
Fidelity Investments first reported a position in TERN in Q1 2021 and held it in 21 quarters. The position peaked at $90.5M in Q1 2023. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.
- Fidelity Investments reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Fidelity Investments sold 295,622 Terns Pharmaceuticals shares in Q2 2026, an estimated $15.6M.
- Fidelity Investments first reported a position in Terns Pharmaceuticals in Q1 2021 and held it in 21 quarters.
- Fidelity Investments's Terns Pharmaceuticals position peaked at $90.5M in Q1 2023.
- 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.
Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.